CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Acadia Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: ACADIA Pharmaceuticals Inc. | ACADIA PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2004

First marketed drug

Apr 29, 2016

First NDA

Apr 29, 2016

Last known activity

Dec 11, 2025

Timeline

1990s

  1. Jan 1, 1993

    Acadia Pharmaceuticals— Founded

2010s

  1. Apr 29, 2016

    pimavanserin— NDA Organization

  2. Apr 29, 2016

    pimavanserin— NDA Secondary Org

2020s

  1. Aug 25, 2020

    CerSci Therapeutics— Acquired

  2. Mar 10, 2023

    trofinetide— Marketing Organization

Drugs by trial phase (8 distinct, 50 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (3 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (49)

Details

Founded
San Diego, CA, US Jan 1, 1993
First NDA
Apr 29, 2016
Last known activity
Dec 11, 2025

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Breakthrough therapy